In 2025, everyone enrolled in Part D will have their annual out-of-pocket drug costs capped at $2,000. In future years, that cap will rise in step with the rate of change in Part D costs.
1d
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription ...
Despite its government spending more than any other on health care both per capita and as a percentage of GDP, spending over $4.5 trillion in 2022, the United States has the lowest life expectancy at ...
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
Scientists have devised a free AI algorithm that they believe will make finding new medicines far more efficient.
Utah's life sciences sector is a significant economic powerhouse, but the misguided the Medication Affordability and Patent ...
Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.
Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback